Atlas Trials

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

Clinical trial NCT04329403 · WITHDRAWN

Trial details

NCT number
NCT04329403
Sponsor
Aurobindo Pharma Ltd
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2020-07-01
Primary completion
2021-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.